Government proposes 30% cap on cancer drug trade margins as price gaps reach 1,000%

The government's proposal to cap trade margins at 30% of the MRP for non-scheduled cancer drugs aims to address high price gaps, which can reach 1,000% of the cost. The plan, still ongoing, would l…

Open in the NEWX app